Pimitespib is effective on cecal GIST in a mouse model of familial GISTs with KIT-Asp820Tyr mutation through KIT signaling inhibition-Reference-Cited by-同舟云学术

Pimitespib is effective on cecal GIST in a mouse model of familial GISTs with KIT-Asp820Tyr mutation through KIT signaling inhibition

Published:2021-12 Issue: Volume:123 Page:104692
ISSN:0014-4800
Container-title:Experimental and Molecular Pathology
language:en
Short-container-title:Experimental and Molecular Pathology

Author:

Kihara Takako,Yuan Jiayin,Watabe Tadashi,Kitajima Kazuhiro,Kimura Neinei,Ohkouchi Mizuka,Hashikura Yuka,Ohkubo Shuichi,Takahashi Tsuyoshi,Hirota Seiichi

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Molecular Biology,Pathology and Forensic Medicine

Reference40 articles.

1. Heat shock protein 90 inhibition in imatinib-resistant gastrointestinal stromal tumor;Bauer;Cancer Res.,2006

2. A phase 2 study of the Hsp90 inhibitor AUY922 as treatment for patients with refractory gastrointestinal stromal tumors;Bendell;Cancer Investig.,2016

3. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-KIT and platelet-derived growth factor receptors;Buchdunger;J. Pharmacol. Exp. Ther.,2000

4. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus;Chabot;Nature,1988

5. Imatinib inhibits various types of activating mutant KIT found in gastrointestinal stromal tumors;Chen;Int. J. Cancer,2003

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular safety of pimitespib in patients with advanced solid tumors: An open‐label, nonrandomized, phase 1 study;Cancer;2024-07-10

2. Pimitespib for the treatment of advanced gastrointestinal stromal tumors and other tumors;Future Oncology;2023-12-05

3. Capsaicin binds the N-terminus of Hsp90, induces lysosomal degradation of Hsp70, and enhances the anti-tumor effects of 17-AAG (Tanespimycin);Scientific Reports;2023-08-23

4. Long-term response to pimitespib in postoperative recurrent gastrointestinal stromal tumors with PDGFRA D842V mutation: a case report;Surgical Case Reports;2023-04-07

5. Current status of and future prospects for the treatment of unresectable or metastatic gastrointestinal stromal tumours;Gastric Cancer;2023-03-13